Physical functioning, mental health and quality of life in different congenital heart defects: Comparative analysis in 3538 patients from 15 countries by P. Moons et al.
Journal Pre-proof
Physical functioning, mental health and quality of life in different congenital heart
defects: Comparative analysis in 3538 patients from 15 countries
Philip Moons, PhD, Koen Luyckx, PhD, Corina Thomet, MSc, Werner Budts, MD,
PhD, Junko Enomoto, PhD, Maayke A. Sluman, MD, PhD, Chun-Wei Lu, MD, PhD,
Jamie L. Jackson, PhD, Paul Khairy, MD, PhD, Stephen C. Cook, MD, Shanthi
Chidambarathanu, FNB, Luis Alday, MD, Katrine Eriksen, MSc, Mikael Dellborg,
MD, PhD, Malin Berghammer, PhD, Bengt Johansson, MD, PhD, Andrew S. Mackie,
MD, Samuel Menahem, MD, DMedHSc, Maryanne Caruana, MD, PhD, Gruschen
Veldtman, MD, Alexandra Soufi, MD, Susan M. Fernandes, LPD, PA-C, Kamila
White, PhD, Edward Callus, PhD, Shelby Kutty, MD, PhD, Fouke Ombelet, MSc, Silke
Apers, PhD, Adrienne H. Kovacs, PhD, on behalf of the APPROACH-IS consortium
and the International Society for Adult Congenital Heart Disease (ISACHD)
PII: S0828-282X(20)30317-2
DOI: https://doi.org/10.1016/j.cjca.2020.03.044
Reference: CJCA 3699
To appear in: Canadian Journal of Cardiology
Received Date: 13 February 2020
Revised Date: 28 March 2020
Accepted Date: 29 March 2020
Please cite this article as: Moons P, Luyckx K, Thomet C, Budts W, Enomoto J, Sluman MA, Lu C-W,
Jackson JL, Khairy P, Cook SC, Chidambarathanu S, Alday L, Eriksen K, Dellborg M, Berghammer
M, Johansson B, Mackie AS, Menahem S, Caruana M, Veldtman G, Soufi A, Fernandes SM, White K,
Callus E, Kutty S, Ombelet F, Apers S, Kovacs AH, on behalf of the APPROACH-IS consortium and the
International Society for Adult Congenital Heart Disease (ISACHD), Physical functioning, mental health
and quality of life in different congenital heart defects: Comparative analysis in 3538 patients from 15
countries, Canadian Journal of Cardiology (2020), doi: https://doi.org/10.1016/j.cjca.2020.03.044.
This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition
of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of
record. This version will undergo additional copyediting, typesetting and review before it is published
in its final form, but we are providing this version to give early visibility of the article. Please note that,
during the production process, errors may be discovered which could affect the content, and all legal
disclaimers that apply to the journal pertain.
© 2020 Published by Elsevier Inc. on behalf of the Canadian Cardiovascular Society.
1 
 
Physical functioning, mental health and quality of life in different congenital heart 
defects: Comparative analysis in 3538 patients from 15 countries 
 
Brief title: Outcomes in congenital heart defects 
 
 
Philip Moons, PhD,a,b,c,d Koen Luyckx, PhD,e,f Corina Thomet, MSc,a,g Werner Budts, MD, 
PhD,h,i Junko Enomoto, PhD,j Maayke A. Sluman, MD, PhD,k,l Chun-Wei Lu, MD, PhD,m 
Jamie L. Jackson, PhD,n Paul Khairy, MD, PhD,o Stephen C. Cook, MD,p Shanthi 
Chidambarathanu, FNB,q Luis Alday, MD,r Katrine Eriksen, MSc,s Mikael Dellborg, MD, 
PhD,c,t,u Malin Berghammer, PhD,c,v,w Bengt Johansson, MD, PhD,x Andrew S. Mackie, MD,y 
Samuel Menahem, MD, DMedHSc,z Maryanne Caruana, MD, PhD,aa Gruschen Veldtman, 
MD,ab Alexandra Soufi, MD,ac Susan M. Fernandes, LPD, PA-C,ad Kamila White, PhD,ae 
Edward Callus, PhD,af,ag Shelby Kutty, MD, PhD,ah,ai , Fouke Ombelet, MSc, a Silke Apers, 
PhD,a Adrienne H. Kovacs, PhD,aj,ak on behalf of the APPROACH-IS consortium and the 
International Society for Adult Congenital Heart Disease (ISACHD) 
 
 
 
a KU Leuven Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium 
b
 Institute of Health and Care Sciences, University of Gothenburg, Gothenburg, Sweden 
c
 Centre for Person-Centred Care (GPCC), University of Gothenburg, Gothenburg, Sweden 
d
 Department of Paediatrics and Child Health, University of Cape Town, Cape Town, South 
Africa  
e
 KU Leuven School Psychology and Development in Context, KU Leuven, Leuven, Belgium  
2 
 
f UNIBS, University of the Free State, Bloemfontein, South Africa 
g Center for Congenital Heart Disease, Department of Cardiology, Inselspital - Bern 
University Hospital, University of Bern, Bern, Switzerland 
h
 Division of Congenital and Structural Cardiology, University Hospitals Leuven, Leuven, 
Belgium 
i KU Leuven Department of Cardiovascular Sciences, KU Leuven, Leuven, Belgium 
j Department of Education, Toyo University, Tokyo, Japan 
k Coronel Institute of Occupational Health, Amsterdam UMC, University of Amsterdam, 
Amsterdam, the Netherlands 
l Department of Cardiology, Jeroen Bosch Hospital, ‘s Hertogenbosch, the Netherlands 
m Adult Congenital Heart Center, Department of Pediatrics, National Taiwan University 
Children’s Hospital, Taipei, Taiwan 
n Center for Biobehavioral Health, Nationwide Children’s Hospital, Columbus, OH, USA 
o Adult Congenital Heart Center, Montreal Heart Institute, Université de Montréal, Montreal, 
Canada 
p Adult Congenital Heart Disease Center, Helen DeVos Children's Hospital, Grand Rapids, 
MI, USA 
q Pediatric Cardiology, Frontier Lifeline Hospital (Dr. K. M. Cherian Heart Foundation), 
Chennai, India 
r
 Division of Cardiology, Hospital de Niños, Córdoba, Argentina 
s Adult Congenital Heart Disease Center, Oslo University Hospital - Rikshospitalet, Oslo, 
Norway 
t
 Adult Congenital Heart Unit, Sahlgrenska University Hospital/Östra, Gothenburg, Sweden 
u Institute of Medicine, The Sahlgrenska Academy at University of Gothenburg, Sweden 
v Department of Health Sciences, University West, Trollhättan, Sweden 
3 
 
w
 Department of Paediatrics, Queen Silvia Children’s Hospital, Sahlgrenska University 
Hospital, Gothenburg, Sweden 
x Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden 
y
 Division of Cardiology, Stollery Children’s Hospital, University of Alberta, Edmonton, 
Canada 
z
 Monash Heart, Monash Medical Centre, Monash University, Melbourne, Australia 
aa
 Department of Cardiology, Mater Dei Hospital, Birkirkara Bypass, Malta 
ab
 Adult Congenital Heart Disease Center, Cincinnati Children's Hospital Medical Center, 
Cincinnati, OH, USA 
ac Department of Congenital Heart Disease, Louis Pradel Hospital, Hospices civils de Lyon, 
Lyon, France 
ad
 Adult Congenital Heart Disease Program at Stanford, Lucile Packard Children’s Hospital 
and Stanford Health Care, Palo Alto, CA, USA 
ae Adult Congenital Heart Disease Center, Washington University and Barnes Jewish Heart & 
Vascular Center, University of Missouri, Saint Louis, MO, USA 
af
 Clinical Psychology Service, IRCCS Policlinico San Donato, Milan, Italy 
ag
 Department of Biomedical Sciences for Health, Università degli Studi di Milano, Milan, 
Italy 
ah Adult Congenital Heart Disease Center University of Nebraska Medical Center/ Children’s 
Hospital and Medical Center, Omaha, NE, USA 
ai Taussig Heart Center, Johns Hopkins School of Medicine, Baltimore, MD, USA 
aj
 Peter Munk Cardiac Centre, University Health Network, University of Toronto, Toronto, 
Canada  
ak Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA 
 
4 
 
 
 
Correspondence: Philip Moons, KU Leuven Department of Public Health and Primary Care, 
Kapucijnenvoer 35, Box 7001, B-3000 Leuven, Belgium. Tel.: +32 16 373315; E-mail: 
philip.moons@kuleuven.be  
 
 
Word count: 5221 words 
 
  
5 
 
Brief Summary 
We compared physical functioning, mental health and quality of life (QoL) in 3538 patients 
with different subtypes of congenital heart diseases (CHD). Patients with coarctation of the 
aorta and those with isolated aortic valve disease reported the best physical functioning, 
mental health and QoL. Patients with cyanotic heart disease or Eisenmenger syndrome had 
worst outcomes. However, functional status rather than the heart defect shapes the outcomes.  
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Abstract 
Background: We compared physical functioning, mental health and quality of life (QoL) of 
patients with different subtypes of congenital heart diseases (CHD) in a large international 
sample, and investigated the role of functional class in explaining the variance in outcomes 
across heart defects. 
Methods: In the cross-sectional APPROACH-IS study, we enrolled 4,028 adult CHD patients 
from 15 countries. Diagnostic groups with at least 50 patients were included in these analyses, 
yielding a sample of 3,538 patients (median age=32y; 52% women). Physical functioning, 
mental health and QoL were measured with the SF-12 health status survey, Hospital Anxiety 
and Depression Scale (HADS), linear analog scale (LAS) and Satisfaction with Life Scale, 
respectively. Functional class was assessed using the patient-reported New York Heart 
Association (NYHA) class. Multivariable general linear mixed models were applied to assess 
the relationship between the type of CHD and patient-reported outcomes, adjusted for patient 
characteristics, and with country as random effect.  
Results: Patients with coarctation of the aorta and those with isolated aortic valve disease 
reported the best physical functioning, mental health and QoL. Patients with cyanotic heart 
disease or Eisenmenger syndrome had worst outcomes. The differences were statistically 
significant, above and beyond other patient characteristics. However, the explained variances 
were small (0.6-4.1%), and decreased further when functional status was added to the models 
(0.4-0.9%). 
Conclusions: Some types of CHD predict worse patient-reported outcomes. However, it 
appears that it is the functional status associated with the heart defect rather than the heart 
defect itself that shapes the outcomes. 
Keywords: heart defects, congenital; patient-reported outcomes; quality of life; health status; 
effect sizes; multilevel   
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Introduction 
Over the past four decades, research on quality of life (QoL) in persons with congenital heart 
disease (CHD) has grown exponentially.1 The mounting interest in QoL among affected 
patients coincided with increasing longevity.2 Indeed, after the dramatic improvements in 
patient survival in the second half of the 20th century, clinicians and researchers were 
intrigued by the question of what the lives of patients with CHD looked like and whether the 
heart defect itself had a direct impact on QoL.1  
Together with increased interest in QoL, there has been rising awareness of the 
importance of patient-reported health status.3 It has been argued that patients' perspectives 
should be routinely incorporated within health metrics.3 Perceived health, from both physical 
and mental perspectives, ought to be evaluated to obtain a comprehensive view of the 
patients’ status. Further, in different cardiac populations, patient-reported outcomes are found 
to be independent predictors of mortality.3 
There are previous studies that have indicated that a higher complexity of CHD is 
associated with poorer physical functioning and QoL.4, 5 However, within complexity 
categories, there may be large variation in outcomes according to the type of CHD. For 
instance, in one study adults with transposition of the great arteries (TGA) had an average SF-
36 physical functioning of 93 on a scale from 0 (worst) to 100 (best),6 whereas in another 
study patients with single-ventricle physiology had a much lower average physical 
functioning score of 81.6.7 This is meaningful because both of these subtypes are categorized 
as complex heart defects.8 Conversely, there are examples in which similar patient-reported 
outcomes have been observed among patients with defects of great vs. moderate complexity. 
To illustrate, cohorts of patients who have undergone atrial switch operations for TGA 
(categorized as a defect of great complexity) and patients with repaired tetralogy of Fallot (a 
defect of moderate complexity) both reported average scores on a QoL linear analog scale of 
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80 on a scale from 0 (worst QoL) to 100 (best QoL).9, 10 These apparent inconsistencies 
warrant direct comparison of the physical functioning and QoL of patients with specific heart 
defects. Such studies, however, have been scarce, primarily because large sample sizes are 
needed to have sufficient patients for each diagnostic group.  
The aims of the present study were therefore (i) to compare the physical functioning, 
mental health and QoL in patients with different heart defects drawn from a large 
international sample; and (ii) to investigate to what extent the outcome variance is predicted 
by patients’ functional class rather than the heart defect itself. 
 
Methods 
Study population and procedure 
In 2013-2015, we conducted the ‘Assessment of Patterns of Patient-Reported Outcomes in 
Adults with Congenital Heart disease – International Study’ (APPROACH-IS). This was a 
cross-sectional study involving 15 countries from 5 continents: Argentina, Australia, 
Belgium, Canada, France, India, Italy, Japan, Malta, Norway, Sweden, Switzerland, Taiwan, 
the Netherlands, and the United States of America (USA).11 Patients we eligible for study 
inclusion if they met the following criteria: (i) diagnosis of CHD; (ii) aged ≥18 years; (iii) 
diagnosis established before adolescence; (iv) continued follow-up at a CHD center or 
included in a national/regional registry; and (v) physical, cognitive, and language capabilities 
required to complete self-report questionnaires. Patients with prior heart transplantation or 
primary pulmonary hypertension were excluded.11 Patients who met inclusion criteria were 
contacted by mail or were approached during an outpatient visit. Overall, 4,028 adults with 
CHD were enrolled in APPROACH-IS.12 For the present study, only diagnostic groups 
having at least 50 patients were included in the analyses, yielding a sample of 3,538 patients 
(88% of the total recruited sample).  
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 The study was conducted in keeping with the Declaration of Helsinki and was 
approved by the Institutional Review Board of the University Hospitals Leuven/KU Leuven 
Belgium (coordinating center) and by the local institutional review boards of the participating 
centers (when required). All participants provided written informed consent. Detailed 
information on the rationale, design, and methods of APPROACH-IS can be found in a 
dedicated methods paper.11  
 
Measures 
Patient characteristics included demographic data, such as sex, age, marital status, educational 
level, employment status, and patient-reported New York Heart Association (NYHA) 
functional class, which were collected using a self-report questionnaire. Specific diagnoses as 
well as the complexity of the patients’ heart defects (simple, moderate, or great complexity) 
were extracted from the medical records. 
 Self-reported physical functioning was measured using the Physical Component 
Summary (PCS) of the 12-item Short Form Health Survey (SF-12).13 The score ranges from 0 
to 100, with higher scores representing better physical functioning. Mental health was 
assessed using the Mental Component Summary (MCS) of the SF-12 13 which also ranges 
from 0 to 100, and the anxiety and depression subscales of the Hospital Anxiety and 
Depression Scale (HADS), which range from 0 to 21.14 Whereas higher SF-12 scores 
represent better physical and mental health status, higher scores on the HADS anxiety and 
depression subscales reflect greater symptoms. QoL was evaluated using a Linear Analog 
Scale (LAS) 15 and the Satisfaction With Life Scale.16 The LAS ranges from 0 (worst 
imaginable QoL) to 100 (best imaginable QoL) and the Satisfaction With Life Scale ranges 
from 5 (extremely dissatisfied) to 35 (extremely satisfied). Supplementary Table S1 provides 
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an expanded definition of the variables measured as well as the interpretation of scores for the 
individual questionnaires.  
 
Statistical analyses 
Continuous data are presented as means and standard deviations if normally distributed and as 
medians and interquartiles ranges (IQR) if not normally distributed. Categorical variables are 
represented by percentages. Multivariable general linear mixed models (GLMM) were applied 
to assess the relationship between the type of CHD and physical functioning, mental health 
and QoL, adjusted for patient characteristics (age, sex, educational status, employment status, 
and marital status), and with country as a random effect. These patient characteristics have 
previously been related to patient-reported outcomes.17 The heart defect with the highest score 
on the respective outcomes was used as reference group. A (pseudo) R2 statistic was derived 
from the model χ2.18 This is an approximate estimate for the percentage of explained variance. 
When reported for the effect of the type of heart defect, these approximations are analogous to 
the semi-partial R2. 
 Data were visualized using ridgeline plots, expressing the density of the distribution of 
scores for the different heart defects (see Supplementary Box S1 for more details). To 
investigate the clinical difference between the respective heart defects and the reference group 
(=highest score), we calculated the standardized effect size (Cohen’s d) for each type of 
defect and reported it in terms of absolute standardized effect size. The following cut-off 
values were used: 0.2-0.5 indicative of a small effect; 0.5-0.8 a moderate effect; and >0.8 a 
large effect.19 
The proportion of missing values in the outcomes was small (5-8%). Therefore, 
multiple imputation was not used to address missing values as this would unnecessarily 
complicate data analysis, and only patients for whom full data were available for all variables 
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of interest were included in the GLMM. Data analysis was performed using IBM SPSS 
Statistics for Windows, version 25 (IBM Corp., Armonk, NY, USA). Ridgeline plots were 
made using Rstudio, version 1.1.463. A p-level <0.05 was used as the cut-off for statistical 
significance, and statistical tests were two-sided.  
 
Results 
Sample characteristics 
The current sample was comprised of 3,538 patients with a median age of 32 years and 52% 
were women. The majority of patients had a high school degree, worked part or full time, and 
were married or living with a partner. With regard to medical characteristics, 49% had CHD 
of moderate complexity and 55% reported they were in NYHA functional class I (i.e. 
asymptomatic). Demographic and medical characteristics of the sample are described in 
Supplementary Table S2, and were consistent with those of the larger sample included in 
APPROACH-IS.12 The distribution of the NYHA functional class in the different subtypes of 
CHD is described in Supplementary Table S3. 
 
Physical functioning 
Patients with coarctation of the aorta received the highest mean score on the physical 
component summary (83.6±17.2), while patients with cyanotic heart disease or Eisenmenger 
syndrome had the lowest mean score (53.5±21.8). The ridgeline plot shown in Figure 1 
visually demonstrates that scores of patients with cyanotic heart disease/Eisenmenger 
syndrome were lower than those of other types of heart defects. When adjusted for patient 
characteristics, general linear mixed models showed that physical functioning was 
significantly lower in 12 heart defects compared to coarctation of the aorta (Figure 1). The 
type of heart defect explained 3.9% of the variance of the physical component summary. 
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When NYHA functional class was added to the model, the semi-partial R2 for the type of 
heart defect dropped to 0.8%, whereas the semi-partial R2 for NYHA was 36.5% 
As demonstrated in the bar chart in Figure 1, scores of patients with cyanotic heart 
disease/Eisenmenger syndrome differed with a large standardized effect size from the 
reference group, namely patients with coarctation of the aorta. For patients with congenitally 
corrected TGA, pulmonary atresia, Fontan circulation, and Ebstein anomaly, a moderate 
difference was found with the reference group. A small difference was observed for several 
other diagnoses, as shown in Figure 1.  
 
Mental health 
In patients with coarctation of the aorta, the highest mean score on the mental component 
summary (76.3±16.7) and the lowest mean score for depression (2.5±2.7) were observed 
(Figure 2). Patients with isolated aortic valve disease had the lowest level of anxiety 
(4.7±3.8). People with cyanotic heart disease/Eisenmenger syndrome consistently had the 
worst scores on mental health (61.2±20.2), depression symptoms (7.5±4.6) and anxiety 
symptoms (5.2±4.1). For the mental component summary, patients with TGA, Fontan 
circulation, cyanotic heart disease/Eisenmenger syndrome, or repaired ductus 
arteriosus/ASD/VSD had significantly lower scores compared to the reference group, adjusted 
for patient characteristics. Patients with TGA, Fontan circulation, or cyanotic heart 
disease/Eisenmenger syndrome scored significantly lower than the reference group for 
anxiety symptoms. Patients with TGA, pulmonary atresia, Fontan circulation, cyanotic heart 
disease/Eisenmenger syndrome, or atrioventricular septal defect/ostium primum ASD scored 
significantly lower than the reference group in depression symptoms (Figure 2). The 
explained variance for the mental component summary, anxiety and depression was 1%, 1% 
and 0.7%, respectively. When adjusted for NYHA class, the semi-partial R2 for the type of 
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heart defect declined to 0.7%, 0.4% and 0.5%, respectively. The semi-partial R2 for NYHA 
was 14.4% for the mental component summary, 7.2% for anxiety, and 9.9% for depression.  
 Effect sizes (Figure 2) showed that the difference between the mental component 
summary of patients with cyanotic heart disease/Eisenmenger syndrome and the reference 
group was large. The difference was moderate for anxiety in patients with Fontan circulation 
and cyanotic heart disease/Eisenmenger syndrome. A large difference was also found for 
depression in patients with cyanotic heart disease/Eisenmenger syndrome. For the other 
differences, the effects were small or negligible (Figure 2). 
 
Quality of life 
Patients with isolated aortic valve disease had the highest QoL score, both on the LAS 
(82.0±13.8) and the Satisfaction with Life Scale (27.1±6.0). Patients with cyanotic heart 
disease/Eisenmenger syndrome reported the lowest scores on QOL (67.1±21.8; 22.4±7.1) 
(Figure 3). Compared to the reference group, a significantly lower score on the LAS was 
observed in patients with congenitally corrected TGA, Fontan circulation, cyanotic heart 
disease/Eisenmenger syndrome, and conduits. On the Satisfaction with Life Scale, patients 
with complete TGA, Fontan circulation, and cyanotic heart disease/Eisenmenger syndrome 
scored significantly lower, when adjusted for patient characteristics. The semi-partial R2 for 
the type of heart defect on the LAS was 1.1% and on the Satisfaction with Life Scale 1.4%. 
These explained variances dropped to 0.4% and 0.6%, respectively, when NYHA class was 
added to the generalized linear mixed model. On the other hand, semi-partial R2 for NYHA 
was 10.7% for the LAS and 7.1% for the Satisfaction with Life Scale. 
 The effect size for the score on the LAS in patients with cyanotic heart 
disease/Eisenmenger syndrome was large, and moderate for people with congenitally 
corrected TGA. On the Satisfaction with Life Scale, a moderate effect was found in patients 
14 
 
with Fontan circulation and cyanotic heart disease/Eisenmenger syndrome. The other effects 
were small or negligible (Figure 3). 
 
Discussion 
This was the first study in which the wide spectrum of CHD subtypes were compared using a 
comprehensive set of patient-reported outcomes. Most previous studies investigating patient-
reported outcomes collapsed across a heterogeneous group of heart defects or focused on one 
particular heart lesion.1 Few studies compared outcomes between two subtypes of heart 
defects. In these studies, heart defects of different complexity levels were compared,20-22 or 
different interventions for the same condition were compared.23 The present study 
demonstrated that patients with isolated aortic valve disease or coarctation of the aorta had the 
best scores on patient-reported outcomes, whereas patients with cyanotic heart 
disease/Eisenmenger syndrome consistently score lowest.  
It may be surprising that individuals with coarctation of the aorta report such positive 
patient-reported outcomes, since it is a categorized as a heart defect of moderate complexity. 
However, it has been shown that exercise capacity long-term after treatment for coarctation of 
the aorta is preserved and comparable to healthy controls.24 Within the adult population of 
CHD, patients with coarctation of the aorta seem to have the best exercise capacity,25 which is 
likely to reflect in good physical functioning. Further, mental health among patients within 
this CHD subgroup has been found to be comparable with the scores of a healthy 
population,26 and the proportion of patients with coarctation of the aorta who developed 
depression (1.5%) was the lowest when compared to other heart defects.27 A potential 
explanation for this finding is that coarctation of the aorta is usually treated without 
cardiopulmonary bypass and thereby the risk for neurological and cognitive side-effects is 
lower. Overall, these findings suggest that patients with coarctation of the aorta and isolated 
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aortic valve disease could be equally considered as reference groups as those with ASD or 
VSD, which have sometimes been used as a “healthy” comparison group.  
 The fact that people with cyanotic heart defects and Eisenmenger syndrome received 
lowest scores on all patient-reported outcomes was anticipated. Research and clinical 
experiences indicate that these patients have significantly impaired exercise capacity.25, 28 The 
level of anxiety in these patients was high, and was in keeping with the findings of a large-
scale study in patients with Eisenmenger in France.29 The level of depression in cyanotic heart 
disease/Eisenmenger syndrome in APPROACH-IS was actually even higher than that in the 
French cohort.29  
 Despite reaching statistical significance, the explained variance of the type of heart 
defect on the respective outcomes was small (0.7-3.9%). When adjusted for NYHA functional 
class, the explained variance was even smaller (0.4-0.8%), whereas the explained variance of 
the NYHA ranged from 7.1-36.5%. This shows that the functional impact of the heart defect 
rather than the heart defect itself affects patient-reported outcomes. This was most 
pronounced for physical health status. In line with these findings, it is understandable that the 
2018 AHA/ACC guidelines for the management of adults with CHD proposed a new 
classification scheme, in which both anatomical complexity and current physiological stage of 
the patient are included, the so-called ACHD-AP score.8 The first validity evaluation showed 
that adding the physiological component to anatomical complexity is able to better predict 15-
year mortality.30 Other functional indices, such as the Congenital Heart Disease Functional 
Index, also seem more predictive than anatomical classifications.31 The relationship between 
functional indices and QoL was found to be larger compared to anatomical complexity and 
QoL.32 
 Findings of this study can inform clinicians about patient-reported outcomes as 
perceived by patients with different subtypes of CHD. Subgroups of patients with specific 
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defects who may be prone to developing worse outcomes have been identified. The present 
study also carries implications for research. Results from this large international sample may 
serve as a benchmark for previous and future studies on patient-reported outcomes. For 
instance, this study demonstrates that the composition of the sample may impact the outcomes 
of the study. Indeed, an overrepresentation of patients with coarctation of the aorta or isolated 
aortic valve disease would now be expected to inflate scores and may lead to an 
overestimation of the status of patients with CHD. Further, investigators should not assume 
that patient-reported outcomes vary by defect complexity in a linear fashion, as in this study a 
moderately complex defect, namely coarctation of the aorta, was associated with better 
outcomes than various mild heart lesions.  
 
Methodological considerations 
The present study has several strengths. We included more than 3,500 patients from 15 
countries; we had a high degree of complete data; and we used valid and reliable instruments 
to comprehensively assess the self-reported outcomes in this international sample. For the 
present study, we conducted multilevel analysis and adjusted for patient characteristics that 
have been shown to predict patient-reported outcomes.17 In addition to statistical significance, 
we also reported effect sizes, which allowed us to appraise the magnitude of the differences in 
a standardized way. The visualization technique of the ridgeline plots provides insights into 
the density of distribution of scores, which extends the typical reporting of central tendency 
and dispersion measures. 
 However, we have to bear in mind some limitations inherent to APPROACH-IS that 
may hamper generalizability. It was a cross-sectional study (not allowing conclusions in terms 
of causality), for most participating countries data from only one center were available, 
patients who were physically or mentally incapable of completing the questionnaires were not 
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represented, and there was no healthy control group.17 A control group could have allowed us 
to put our findings more into perspective. However, a meta-analysis comprising 234 studies 
indicated that patients with moderate or complex CHD generally have worse physical 
functioning, yet an equal mental health than healthy individuals.4 Patients with mild heart 
defects did not differ from healthy persons.4 
For the present study, defects with very low prevalence, such as truncus arteriosus, 
tricuspid atresia or pulmonary atresia that were not treated with a Fontan operation, and 
infundibular right ventricular outflow obstruction, were not included in the analyses. These 
less prevalent heart defects accounted for 12% of the APPROACH-IS sample. Future studies 
in adults with CHD will also include patients with heart defects that were lethal in infancy 
until two decades ago, e.g. hypoplastic left heart syndrome, because more of these patients are 
now reaching adulthood. The categorization of CHD used in this study was mutually 
exclusive. The most severe defect was reported, not including combinations with other heart 
lesions (eg TGA with VSD). Further, the current study did not allow an investigation of the 
impact of different treatment strategies. For instance, it could be interesting to compare the 
outcomes of patients with different surgical approaches for the same lesion (eg, 
ventriculotomy vs trans-atrial/trans-pulmonary approach in tetralogy of Fallot). The type of 
operation, or the specifics on the material used, was not available in APPROACH-IS. Finally, 
we did not measure extracardiac drivers for outcomes. Some syndromes may have systemic 
and neurocognitive consequences, impacting on physical functioning, mental health and 
QoL.33 Health behaviors, such as smoking, drug use and alcohol consumption, also may have 
a differential impact on outcomes in different heart defects.34, 35 These are avenues for future 
research. 
 
Conclusions 
18 
 
This largescale international study showed that some types of CHD predict worse patient-
reported outcomes. However, the outcomes were shaped by the functional status associated 
with the heart defect rather than the heart defect itself. Indeed, the explained variances of the 
subtype of heart defect were small, and decreased further when the functional status was 
added to the models. Hence, it is important that patients are not only classified based on their 
anatomical complexity, but also on their current physiological and functional status. 
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Figure legends 
Figure 1: Physical functioning in patients with different heart defects and its comparison to 
the heart defect with the highest score 
Figure 2: Mental health in patients with different heart defects and its comparison to the heart 
defect with the highest score 
Figure 3: Quality of life in patients with different heart defects and its comparison to the heart 
defect with the highest score 
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Figure 1: Physical functioning in patients with different heart defects and its comparison to the heart 
defect with the highest score  
 
Legend: ASD=Atrial Septal Defect; VSD=Ventricular Septal Defect 
  
27 
 
Figure 2: Mental health in patients with different heart defects and its comparison to the heart defect 
with the highest score 
 
Legend: ASD=Atrial Septal Defect; VSD=Ventricular Septal Defect   
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Figure 3: Quality of life in patients with different heart defects and its comparison to the heart defect 
with the highest score 
 
Legend: ASD=Atrial Septal Defect; VSD=Ventricular Septal Defect 
 
